Adherence to Antipsychotic Medications For Individuals with Schizophrenia
2024 · Higher is better
Clinician group · Freehold, NJ
2024 · Higher is better
2024 · Higher is better
2024 · Higher is better
CMS files are dated Sep 10, 2026 to Oct 15, 2026·Model ml-4·Coverage and freshness
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Adherence to Antipsychotic Medications For Individuals with Schizophrenia, 2024. Higher is better. It does not predict your own result.
Percentage of individuals at least 18 years of age as of the beginning of the performance period with schizophrenia or schizoaffective disorder who had at least two prescriptions filled for any antipsychotic medication and who had a Proportion of Days Covered (PDC) of at least 0.8 for antipsychotic medications during the performance period.
Published stratum: overall.
Exact public stratum retained; no pooling with other strata.
2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_383_MIPSCQM.pdf.
Published eligible intermediateOutcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: adultsWellCtrl.
Asthma well-controlled (submit the most recent specified asthma control tool result) for patients 18 to 50 with Asthma; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: pedsNoRiskExac.
Patient not at elevated risk of exacerbation for patients 5 to 17 with Asthma; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: pedCtrlNoExacRisk.
Percentage of pediatric patients (aged 5-17 years) with well-controlled asthma, without elevated risk of exacerbation; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Controlling high blood pressure, 2024. Higher is better.
Eligible essential-hypertension patients with most recent blood pressure below 140/90 mmHg in the period.
Missing BP counts as not controlled.
Intermediate outcome; no case-mix adjustment.
Age: 18–85; stratum: overall.
EHR collection; 2024 performance period.
Public reporting completeness and selection limit representativeness.
No overall quality rank or personal-risk estimate.
Published eligible eCQM patient cohort; payer-specific breakdown unavailable.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
CMS published measure-specific 1 stars; benchmark 40; exact collection/stratum/entity level only, not an overall doctor rating. Functional Status After Primary Total Knee Replacement, 2024. Higher is better.
For patients age 18 and older who had a primary total knee replacement procedure, functional status is rated by the patient as greater than or equal to 37 on the Oxford Knee Score (OKS) or a 71 or greater on the KOOS, JR tool at one year (9 to 15 months) postoperatively.
Published stratum: overall.
Exact public stratum retained; no pooling with other strata.
2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original numeric score preserved as raw_value only; display exact publisher star category, never a guessed percentage.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_470_MIPSCQM.pdf.
Published eligible patientReportedOutcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Depression remission at twelve months. Higher is better.
Published depression-remission outcome 12 months ±60 days after index event.
Exact index event bounds are not supplied in the public row; reporting year is not an assumed index cohort.
Age: adults 18+, adolescents 12–17, or published rollup; never pool strata; stratum: adolescents.
EHR collection; 2024 performance period.
Public reporting completeness and selection limit representativeness.
No overall quality rank or personal-risk estimate.
Published eligible eCQM patient cohort; payer-specific breakdown unavailable.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Diabetes: HbA1c poor control (>9%), 2024. Lower is better.
Eligible patients with diabetes whose most recent HbA1c exceeded 9%; absent assessment also counts as poor control.
Intermediate outcome; no case-mix adjustment.
Age: 18–75; stratum: overall.
EHR collection; 2024 performance period.
Public reporting completeness and selection limit representativeness.
No overall quality rank or personal-risk estimate.
Published eligible eCQM patient cohort; payer-specific breakdown unavailable.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Depression remission at twelve months. Higher is better.
Published depression-remission outcome 12 months ±60 days after index event.
Exact index event bounds are not supplied in the public row; reporting year is not an assumed index cohort.
Age: adults 18+, adolescents 12–17, or published rollup; never pool strata; stratum: adults.
EHR collection; 2024 performance period.
Public reporting completeness and selection limit representativeness.
No overall quality rank or personal-risk estimate.
Published eligible eCQM patient cohort; payer-specific breakdown unavailable.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: pedsWellCtrl.
Asthma well-controlled (submit the most recent specified asthma control tool result) for patients 5 to 17 with Asthma; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Depression remission at twelve months. Higher is better.
Published depression-remission outcome 12 months ±60 days after index event.
Exact index event bounds are not supplied in the public row; reporting year is not an assumed index cohort.
Age: adults 18+, adolescents 12–17, or published rollup; never pool strata; stratum: rollup.
EHR collection; 2024 performance period.
Public reporting completeness and selection limit representativeness.
No overall quality rank or personal-risk estimate.
Published eligible eCQM patient cohort; payer-specific breakdown unavailable.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: adultCtrlNoExacRisk.
Percentage of adult patients (aged 18-50 years) with well-controlled asthma, without elevated risk of exacerbation; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: overall.
Overall Percentage for patients (aged 5-50 years) with well-controlled asthma, without elevated risk of exacerbation; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Group result · PY 2024 Group Public Reporting: MIPS Measures and Attestations, 10 Sep 2026
Optimal Asthma Control, 2024. Higher is better.
Composite measure of the percentage of pediatric and adult patients whose asthma is well-controlled as demonstrated by one of three age appropriate patient reported outcome tools and not at risk for exacerbation.
Published stratum: adultsNoRiskExac.
Patient not at elevated risk of exacerbation for patients 18 to 50 with Asthma; 2024 reporting year.
Cohort dates are the QPP performance year (calendar year); exact index-cohort bounds are not published in the row.
Original published percentage; no scaling or reconstructed numerator.
Clinical results may include missing assessments/selection effects; no personal-risk or overall quality claim.
Definition: http://qpp.cms.gov/docs/QPP_quality_measure_specifications/CQM-Measures/2024_Measure_398_MIPSCQM.pdf.
Published eligible outcome cohort; no payer-specific breakdown. Public metadata risk-adjustment flag is not independently treated as proof of modeled risk adjustment.
It does not predict your own result. OpenHealth's doctor ratings are on each doctor's page.
Missing values stay missing. A grey value means the publisher reported no figure, often because there were too few cases. It does not mean the result is bad.
The reviewed data do not publish this result.
Loading…
data.cms.gov · released 10 Sep 2026
data.cms.gov · released 12 Nov 2026
Official public federal aggregate data; cite CMS, no endorsement. Clinical periods are separate from publisher release and operational fetch dates. No government endorsement.
Missing evidence is not zero and does not mean poor care. Source list · Coverage and freshness